What a GLP-1 shopper is
A GLP-1 shopper is a household with at least one member taking a GLP-1 receptor agonist, the drug class that includes semaglutide and tirzepatide, prescribed for type 2 diabetes and weight management. The reason the term entered retail vocabulary is that the medication suppresses appetite, and appetite is what a food retailer sells against.
The interesting question was never whether these households eat less. It was whether the effect is large enough, and durable enough, to show up in category data. It is, and the size is now measured rather than guessed.
What the research measured
The best-evidenced study to date comes from Sylvia Hristakeva at Cornell University, published in the Journal of Marketing Research on 18 December 2025. It uses Numerator panel data covering grocery and foodservice transactions for roughly 150,000 nationally representative US households, combined with survey data identifying GLP-1 use.
Households cut grocery spending by 5.3% within six months of a member starting a GLP-1, and by more than 8% among higher-income households.
The category detail is where it gets useful. The decline is not spread evenly:
| Category group | Direction and size |
|---|---|
| Savory snacks | down about 10% |
| Sweets, baked goods, cookies | similarly large declines |
| Limited-service restaurant spend | down about 8% |
| Yogurt | up, the largest gainer |
| Fresh fruit, nutrition bars, meat snacks | modest increases |
Two findings deserve more attention than the headline number. First, the effect persists at least a year among continuing users, though its magnitude decreases over time, so this is a level shift rather than a permanent slide. Second, spending at limited-service restaurants, which is to say fast food and coffee shops, fell about 8%, a steeper drop than the grocery figure.
Why the second finding matters most in convenience
Convenience competes for the same occasions as quick-service restaurants. If the categories under pressure are savory snacks, sweets and fast food, that describes a large share of a convenience store's impulse business and its foodservice programme at the same time. The categories that grew, yogurt, fresh fruit, nutrition bars and meat snacks, are exactly the ones a convenience store carries thinly or not at all.
That is a distribution question rather than a demand question, and it is answerable. A store where meat snacks occupy one facing is not positioned for a shift toward meat snacks regardless of what happens to demand.
What this research does not say
This is where most commentary on the topic goes wrong, so the limits are worth stating plainly.
It is not a convenience measurement. The panel covers grocery and foodservice transactions. Extending a grocery-panel finding to convenience baskets is an assumption, not a result, and convenience occasions differ enough that the assumption is doing real work.
It does not identify shoppers in your data. No retailer file marks a GLP-1 household. Nothing in a register transaction reveals medication use, and attempting to infer it from purchase patterns produces a segment that is mostly error and raises questions no retailer wants to answer.
It is not a forecast. The study measures households that started treatment, over the window observed. Persistence rates, prescription volumes and eventual population penetration are separate questions with separate evidence.
The size effect is not causal in the way it reads. Higher-income households showed a steeper decline, which most plausibly reflects who could access and sustain the medication during the study window rather than a property of income itself.
How to use it responsibly
Treat the research as a category-level prior, not a segment. The defensible move is to watch your own category mix for the shape the study predicts, a soft decline in savory snacks and sweets alongside firmness in protein and better-for-you items, and to check whether your assortment can capture the second half of that pattern. That is a basket analysis question you can answer from data you already hold.
The short version
- A GLP-1 shopper is a household with a member on a GLP-1 medication; the appetite effect is large enough to appear in category data.
- Cornell and Numerator research on roughly 150,000 households found grocery spending down 5.3% within six months, over 8% for higher-income households.
- Savory snacks fell about 10% and limited-service restaurant spend about 8%, while yogurt, fresh fruit, nutrition bars and meat snacks rose.
- The study covers grocery and foodservice panels, not convenience, and no retailer file identifies these households.
Sources: Cornell University, via EurekAlert; Hristakeva, Journal of Marketing Research, 18 December 2025.